Dem İlaç logo — Türkiye'nin sağlıktaki ulusal gücü, gelecek için, güvenle bü...

Dem İlaç

Türkiye'nin sağlıktaki ulusal gücü, gelecek için, güvenle büyüyor.

Founded 1992 Turkey Turkey 321 employees

General Information

Company Name Dem İlaç
Founded Year 1992
Location Turkey Turkey
Employees 321
Business Model B2B, D2C, B2B2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Dem İlaç. To contact Dem İlaç, visit demilac.com.tr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Dem İlaç

Dem İlaç, founded in 1992, stands as a symbol of quality and trust in Turkey's pharmaceutical industry. With roots dating back to 1970 and an enduring commitment to innovation and reliability, the company has consistently enhanced its offerings to support Turkish medicine. Their ethos, encapsulated by their slogan, "Türkiye'nin sağlıktaki ulusal gücü, gelecek için, güvenle büyüyor," underscores their focus on steady growth and building trust.

The company’s portfolio is broad and diverse, featuring human pharmaceuticals, blood products, oncology drugs, anesthetic agents, and biotechnological and biosimilar products—all sourced from prominent global manufacturers or produced in Turkey’s modern facilities. With over 100 license files in its repertoire, Dem İlaç continues to invest in research and extend its portfolio by forging new international partnerships and licensing agreements.

Staffed by a dynamic, motivated, and innovation-driven team, Dem İlaç leverages its relationships with major Turkish pharmaceutical depots to ensure nationwide distribution.

Taxonomy: pharmaceuticals, biosimilars, drug licensing, product distribution, medical supplies, oncology drugs, anesthetics, plasma products, antibiotics, R&D investment, international partnerships, product portfolio expansion, team development, innovation

Services & Products

Pharmaceutical Production
Research and Development
Innovative Drug Formulation
Contract Manufacturing

Target Customers

Healthcare Professionals Hospitals Pharmacies International Distributors

No funding data available for Dem İlaç yet.

Dem İlaç Alternatives & Competitors

Dem İlaç vs

Your Success is our Mission

364 employees
Biotechnology, Pharmaceutical
Dem İlaç vs

Somos un laboratorio farmacéutico español que lleva más de 85 años fabricando medicamentos de máxima...

2080 employees
Manufacturing, Pharmaceutical
Dem İlaç vs

Rising Pharmaceuticals is an industry leader in marketing and distributing generic prescription phar...

282 employees
Biotechnology, Pharmaceutical

FAQ About Dem İlaç

Türkiye'nin sağlıktaki ulusal gücü, gelecek için, güvenle büyüyor.
Dem İlaç was founded in 1992.
Dem İlaç is headquartered in Turkey.
Dem İlaç has a B2B, D2C and B2B2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Dem İlaç has approximately 321 employees.
Dem İlaç offers: Pharmaceutical Production, Research and Development, Innovative Drug Formulation, Contract Manufacturing.
Top alternatives and competitors to Dem İlaç include Contract Pharmacal Corp, Laboratorios Normon, Rising Pharmaceuticals, FARMACONAL, Hana Pharm. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dem İlaç and Contract Pharmacal Corp are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dem İlaç, https://bouncewatch.com/company/dem-ilac, updated 24 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes